SCHEMBL1799240

SCHEMBL1799240

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)N(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 3/20 0.47
MEN1 O00255 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
TP53 P04637 2/20 0.47
THRB P10828 1/20 0.47
KDM4E B2RXH2 3/20 0.47
SERPINE1 P05121 1/20 0.46
TSHR P16473 1/20 0.46
MAPK10 P53779 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1798112 0.90 SERPINE1 (0.56) MAPTALDH1A1GAALMNAPOLB
SCHEMBL1797141 0.89 SERPINE1 (0.55) MAPTALDH1A1GAALMNAPOLB
SCHEMBL1797139 0.87 MAPT (0.47) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL1015370 0.84 KDM4E (0.60) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL1014777 0.83 ALDH1A1 (0.46) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL17799570 0.83 SERPINE1 (0.50) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL1794335 0.83 SMN1; SMN2 (0.69) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL7125633 0.82 ALDH1A1 (0.62) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL1798978 0.80 SERPINE1 (0.53) MAPTALDH1A1SMN1; SMN2GAACYP1A2
SCHEMBL1797516 0.80 ALDH1A1 (0.50) MAPTALDH1A1SMN1; SMN2GAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 MAPT 2975/4885ALDH1A1 800/4885SMN1; SMN2 1590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.